Literature DB >> 21768282

Effect of deletion of genes involved in lipopolysaccharide core and O-antigen synthesis on virulence and immunogenicity of Salmonella enterica serovar typhimurium.

Qingke Kong1, Jiseon Yang, Qing Liu, Praveen Alamuri, Kenneth L Roland, Roy Curtiss.   

Abstract

Lipopolysaccharide (LPS) is a major virulence factor of Salmonella enterica serovar Typhimurium and is composed of lipid A, core oligosaccharide (C-OS), and O-antigen polysaccharide (O-PS). While the functions of the gene products involved in synthesis of core and O-antigen have been elucidated, the effect of removing O-antigen and core sugars on the virulence and immunogenicity of Salmonella enterica serovar Typhimurium has not been systematically studied. We introduced nonpolar, defined deletion mutations in waaG (rfaG), waaI (rfaI), rfaH, waaJ (rfaJ), wbaP (rfbP), waaL (rfaL), or wzy (rfc) into wild-type S. Typhimurium. The LPS structure was confirmed, and a number of in vitro and in vivo properties of each mutant were analyzed. All mutants were significantly attenuated compared to the wild-type parent when administered orally to BALB/c mice and were less invasive in host tissues. Strains with ΔwaaG and ΔwaaI mutations, in particular, were deficient in colonization of Peyer's patches and liver. This deficiency could be partially overcome in the ΔwaaI mutant when it was administered intranasally. In the context of an attenuated vaccine strain delivering the pneumococcal antigen PspA, all of the mutations tested resulted in reduced immune responses against PspA and Salmonella antigens. Our results indicate that nonreversible truncation of the outer core is not a viable option for developing a live oral Salmonella vaccine, while a wzy mutant that retains one O-antigen unit is adequate for stimulating the optimal protective immunity to homologous or heterologous antigens by oral, intranasal, or intraperitoneal routes of administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768282      PMCID: PMC3187260          DOI: 10.1128/IAI.05398-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  62 in total

1.  Highly efficient method for introducing successive multiple scarless gene deletions and markerless gene insertions into the Yersinia pestis chromosome.

Authors:  Wei Sun; Shifeng Wang; Roy Curtiss
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

Review 2.  Use of genetically modified bacteria to modulate adaptive immunity.

Authors:  Susan M Bueno; Pablo A González; Alexis M Kalergis
Journal:  Curr Gene Ther       Date:  2009-06       Impact factor: 4.391

3.  A sopB deletion mutation enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.

Authors:  Yuhua Li; Shifeng Wang; Wei Xin; Giorgio Scarpellini; Zhaoxing Shi; Bronwyn Gunn; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

Review 4.  Invited review: Breaking barriers--attack on innate immune defences by omptin surface proteases of enterobacterial pathogens.

Authors:  Johanna Haiko; Marjo Suomalainen; Teija Ojala; Kaarina Lähteenmäki; Timo K Korhonen
Journal:  Innate Immun       Date:  2009-04       Impact factor: 2.680

5.  O-antigen-negative Salmonella enterica serovar Typhimurium is attenuated in intestinal colonization but elicits colitis in streptomycin-treated mice.

Authors:  Karin Ilg; Kathrin Endt; Benjamin Misselwitz; Bärbel Stecher; Markus Aebi; Wolf-Dietrich Hardt
Journal:  Infect Immun       Date:  2009-04-13       Impact factor: 3.441

6.  A one-plasmid system to generate influenza virus in cultured chicken cells for potential use in influenza vaccine.

Authors:  Xiangmin Zhang; Wei Kong; Shamaila Ashraf; Roy Curtiss
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

7.  Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA.

Authors:  Yuhua Li; Shifeng Wang; Giorgio Scarpellini; Bronwyn Gunn; Wei Xin; Soo-Young Wanda; Kenneth L Roland; Roy Curtiss
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-29       Impact factor: 11.205

8.  Effect of the O-antigen length of lipopolysaccharide on the functions of Type III secretion systems in Salmonella enterica.

Authors:  Stefanie U Hölzer; Markus C Schlumberger; Daniela Jäckel; Michael Hensel
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

9.  Regulated delayed expression of rfaH in an attenuated Salmonella enterica serovar typhimurium vaccine enhances immunogenicity of outer membrane proteins and a heterologous antigen.

Authors:  Qingke Kong; Qing Liu; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

10.  A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.

Authors:  Benjamin K Billips; Ryan E Yaggie; John P Cashy; Anthony J Schaeffer; David J Klumpp
Journal:  J Infect Dis       Date:  2009-07-15       Impact factor: 5.226

View more
  82 in total

Review 1.  Live attenuated vaccines for invasive Salmonella infections.

Authors:  Sharon M Tennant; Myron M Levine
Journal:  Vaccine       Date:  2015-04-19       Impact factor: 3.641

2.  Genome scanning for conditionally essential genes in Salmonella enterica Serotype Typhimurium.

Authors:  Anita Khatiwara; Tieshan Jiang; Sam-Sun Sung; Turki Dawoud; Jeong Nam Kim; Dhruva Bhattacharya; Hee-Bal Kim; Steven C Ricke; Young Min Kwon
Journal:  Appl Environ Microbiol       Date:  2012-02-24       Impact factor: 4.792

Review 3.  New technologies in developing recombinant attenuated Salmonella vaccine vectors.

Authors:  Shifeng Wang; Qingke Kong; Roy Curtiss
Journal:  Microb Pathog       Date:  2012-11-08       Impact factor: 3.738

Review 4.  Polymyxin: Alternative Mechanisms of Action and Resistance.

Authors:  Michael J Trimble; Patrik Mlynárčik; Milan Kolář; Robert E W Hancock
Journal:  Cold Spring Harb Perspect Med       Date:  2016-10-03       Impact factor: 6.915

5.  A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.

Authors:  Yue Han; Qing Liu; Jie Yi; Kang Liang; Yunan Wei; Qingke Kong
Journal:  Pathog Dis       Date:  2017-11-30       Impact factor: 3.166

6.  Outer membrane vesicles derived from Salmonella Typhimurium mutants with truncated LPS induce cross-protective immune responses against infection of Salmonella enterica serovars in the mouse model.

Authors:  Qiong Liu; Qing Liu; Jie Yi; Kang Liang; Tian Liu; Kenneth L Roland; Yanlong Jiang; Qingke Kong
Journal:  Int J Med Microbiol       Date:  2016-08-25       Impact factor: 3.473

7.  Persistent Infections by Nontyphoidal Salmonella in Humans: Epidemiology and Genetics.

Authors:  Alex Marzel; Prerak T Desai; Alina Goren; Yosef Ilan Schorr; Israel Nissan; Steffen Porwollik; Lea Valinsky; Michael McClelland; Galia Rahav; Ohad Gal-Mor
Journal:  Clin Infect Dis       Date:  2016-01-05       Impact factor: 9.079

8.  Regulated delayed synthesis of lipopolysaccharide and enterobacterial common antigen of Salmonella Typhimurium enhances immunogenicity and cross-protective efficacy against heterologous Salmonella challenge.

Authors:  Chun Huang; Qing Liu; Yali Luo; Pei Li; Qiong Liu; Qingke Kong
Journal:  Vaccine       Date:  2016-08-05       Impact factor: 3.641

9.  A Novel Inhibitor of the LolCDE ABC Transporter Essential for Lipoprotein Trafficking in Gram-Negative Bacteria.

Authors:  Nicholas N Nickerson; Christine C Jao; Yiming Xu; John Quinn; Elizabeth Skippington; Mary Kate Alexander; Anh Miu; Nicholas Skelton; Jessica V Hankins; Michael S Lopez; Christopher M Koth; Steven Rutherford; Mireille Nishiyama
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

10.  The effect of loss of O-antigen ligase on phagocytic susceptibility of motile and non-motile Pseudomonas aeruginosa.

Authors:  Sally Demirdjian; Kristin Schutz; Matthew J Wargo; Joseph S Lam; Brent Berwin
Journal:  Mol Immunol       Date:  2017-10-20       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.